Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma.

BCL10, required for nuclear factor kappaB (NF-kappaB) activation during antigen-driven lymphocyte responses, is aberrantly expressed in mucosa-associated lymphoid tissue-type marginal zone (MZ) lymphomas because of chromosomal translocations. Emu-driven human BCL10 transgenic (Tg) mice, which we created and characterize here, had expanded populations of MZ B cells and reduced follicular and B1a cells. Splenic B cells from Tg mice exhibited constitutive activation of both canonical and noncanonical NF-kappaB signaling pathways is associated with increased expression of NF-kappaB target genes. These genes included Tnfsf13b, which encodes the B-cell activating factor (BAFF). In addition, levels of BAFF were significantly increased in sera from Tg mice. MZ B cells of Tg mice exhibited reduced turnover in vivo and enhanced survival in vitro, indicative of lymphoaccumulation rather than lymphoproliferation as the cause of MZ expansion. In vivo antibody responses to both T-independent, and especially T-dependent, antigens were significantly reduced in Tg mice. Mortality was accelerated in Tg animals, and some mice older than 8 months had histologic and molecular findings indicative of clonal splenic MZ lymphoma. These results suggest that, in addition to constitutive activation of BCL10 in MZ B cells, other genetic factors or environmental influences are required for short latency oncogenic transformation.

[1]  D. Roopenian,et al.  NOTCH is part of the transcriptional network regulating cell growth and survival in mouse plasmacytomas. , 2008, Cancer research.

[2]  K. Yeh,et al.  Overexpression of B cell-activating factor of TNF family (BAFF) is associated with Helicobacter pylori-independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma. , 2008, Blood.

[3]  Uri Hershberg,et al.  Anti‐chromatin antibodies drive in vivo antigen‐specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites , 2007, European journal of immunology.

[4]  M. Du.  MALT lymphoma : recent advances in aetiology and molecular genetics. , 2007, Journal of clinical and experimental hematopathology : JCEH.

[5]  C. Berek,et al.  In Vitro and In Vivo Activation Induces BAFF and APRIL Expression in B Cells1 , 2007, The Journal of Immunology.

[6]  S. Rauser,et al.  MALT1 directs B cell receptor–induced canonical nuclear factor-κB signaling selectively to the c-Rel subunit , 2007, Nature Immunology.

[7]  F. Mackay,et al.  B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling. , 2007, Current opinion in immunology.

[8]  Chen-feng Qi,et al.  Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells. , 2007, Cancer research.

[9]  H. Noels,et al.  The pathogenesis of MALT lymphomas: where do we stand? , 2007, Leukemia.

[10]  S. Ghosh,et al.  Antigen-Receptor Signaling to Nuclear Factor κB , 2006 .

[11]  D. Rawlings,et al.  The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes , 2006, Nature Reviews Immunology.

[12]  G. Widhopf,et al.  Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. , 2006, Immunity.

[13]  P. Marynen,et al.  Selective Expansion of Marginal Zone B Cells in Eμ-API2-MALT1 Mice Is Linked to Enhanced IκB Kinase γ Polyubiquitination , 2006 .

[14]  T. Phan,et al.  Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation , 2006, The Journal of experimental medicine.

[15]  T. Molina,et al.  Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradication , 2005, Gut.

[16]  中川 雅夫.  MALT1 contains nuclear export signals and regulates cytoplasmic localization of BCL10 , 2006 .

[17]  S. Ghosh,et al.  Antigen-receptor signaling to nuclear factor kappa B. , 2006, Immunity.

[18]  P. Marynen,et al.  Selective expansion of marginal zone B cells in Emicro-API2-MALT1 mice is linked to enhanced IkappaB kinase gamma polyubiquitination. , 2006, Cancer research.

[19]  P. Marynen,et al.  Splenic marginal zone lymphoma-like features in API2-MALT1 transgenic mice that are exposed to antigenic stimulation. , 2006, Haematologica.

[20]  A. DeFranco,et al.  Bcl10 can promote survival of antigen-stimulated B lymphocytes. , 2005, Blood.

[21]  K. Yeh,et al.  Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21). , 2005, Blood.

[22]  A. Nicholson,et al.  MALT lymphoma with t(14;18)(q32;q21)/IGH‐MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression , 2005, The Journal of pathology.

[23]  T. Habermann,et al.  Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. , 2004, Blood.

[24]  J. Kearney,et al.  B Cell Positive Selection: Road Map to the Primary Repertoire? , 2004, The Journal of Immunology.

[25]  T. Phan,et al.  Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. , 2004, Immunity.

[26]  A. Rao,et al.  Degradation of Bcl10 Induced by T-Cell Activation Negatively Regulates NF-κB Signaling , 2004, Molecular and Cellular Biology.

[27]  M. Thome.  CARMA1, BCL-10 and MALT1 in lymphocyte development and activation , 2004, Nature Reviews Immunology.

[28]  F. Ajchenbaum‐Cymbalista,et al.  Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. , 2004, Blood.

[29]  Honglin Zhou,et al.  Bcl10 activates the NF-κB pathway through ubiquitination of NEMO , 2004, Nature.

[30]  Honglin Zhou,et al.  Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. , 2004, Nature.

[31]  V. Roschke,et al.  B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. , 2003, Arthritis and rheumatism.

[32]  V. Dixit,et al.  Regulation of NF-κB-Dependent Lymphocyte Activation and Development by Paracaspase , 2003, Science.

[33]  Jürgen Ruland,et al.  Differential requirement for Malt1 in T and B cell antigen receptor signaling. , 2003, Immunity.

[34]  S. Morris,et al.  Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells , 2003, Nature Immunology.

[35]  K. Toellner,et al.  Extrafollicular antibody responses , 2003, Immunological reviews.

[36]  S. Akilesh,et al.  Customized molecular phenotyping by quantitative gene expression and pattern recognition analysis. , 2003, Genome research.

[37]  Chris Bakal,et al.  The MAGUK family protein CARD11 is essential for lymphocyte activation. , 2003, Immunity.

[38]  G. Ott,et al.  T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. , 2003, Blood.

[39]  R. Jonsson,et al.  Attenuated Apoptosis of B Cell Activating Factor–Expressing Cells in Primary Sjögren’s Syndrome , 2003, Laboratory Investigation.

[40]  S. Shinton,et al.  Positive Selection of Anti–Thy-1 Autoreactive B-1 Cells and Natural Serum Autoantibody Production Independent from Bone Marrow B Cell Development , 2003, The Journal of experimental medicine.

[41]  J. Dierlamm.  Genetic abnormalities in marginal zone B-cell lymphoma. , 2003, Haematologica.

[42]  V. Roschke,et al.  BLyS and APRIL Form Biologically Active Heterotrimers That Are Expressed in Patients with Systemic Immune-Based Rheumatic Diseases1 , 2002, The Journal of Immunology.

[43]  N. Harris,et al.  Bethesda proposals for classification of lymphoid neoplasms in mice. , 2002, Blood.

[44]  D. Baltimore,et al.  The combined absence of NF-κB1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[45]  S. Pillai,et al.  Antigen-dependent B-cell development. , 2002, Current opinion in immunology.

[46]  M. Reth.  Oligomeric antigen receptors: a new view on signaling for the selection of lymphocytes. , 2001, Trends in immunology.

[47]  J. Kearney,et al.  Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. , 2001, Immunity.

[48]  T. Mak,et al.  Bcl10 Is a Positive Regulator of Antigen Receptor–Induced Activation of NF-κ B and Neural Tube Closure , 2001, Cell.

[49]  Bruce H. Horwitz,et al.  Nuclear Factor κb Is Required for the Development of Marginal Zone B Lymphocytes , 2000, The Journal of experimental medicine.

[50]  J. Silver,et al.  Positive selection of natural autoreactive B cells. , 1999, Science.

[51]  J. Kearney,et al.  IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. , 1999, Journal of immunology.

[52]  K. Lennert,et al.  Splenic marginal zone lymphomas of mice. , 1999, The American journal of pathology.

[53]  J.M. Adams,et al.  Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. , 1994, The EMBO journal.